PwC will drop cover for weight-loss drugs from employee health plans
Big Four accountancy balks at high cost of medication it says has become ‘cultural phenomenon’
Related reading
Weight-loss drugs are bringing a new commercial reality
The reinforcing feedback loop that has long powered the food industry is being chemically switched off
PwC plans overhaul of global consulting business
Shake-up spurred on by rise of AI and threat of major upheaval across the industry
Can WeightWatchers stay relevant when everyone is on diet drugs?
GLP-1 medications could be the group’s death knell — or grant it a new lease on life
PwC US boss says partners who resist AI have no place at the firm
Consultancy begins overhaul of pricing and services in face of technology undercutting its business
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of…
Eli Lilly shot helped patients lose 29% of body weight
Trial results are a boost to US pharmaceutical company’s booming obesity business